Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:can_metastasize_to |
liver
lungs bones lymph nodes |
| gptkbp:diagnosis |
biopsy
generally better than HER2-positive breast cancer |
| gptkbp:has_type |
gptkb:invasive_ductal_carcinoma
gptkb:invasive_lobular_carcinoma |
| https://www.w3.org/2000/01/rdf-schema#label |
HER2-negative breast cancer
|
| gptkbp:is_affected_by |
environmental factors
lifestyle factors genetic factors |
| gptkbp:is_associated_with |
alcohol consumption
obesity radiation exposure family history of breast cancer estrogen receptor positivity progesterone receptor positivity |
| gptkbp:is_characterized_by |
lack of HER2 protein overexpression
|
| gptkbp:is_common_in |
older women
|
| gptkbp:is_effective_against |
gptkb:triple-negative_breast_cancer
gptkb:HER2-positive_breast_cancer |
| gptkbp:is_linked_to |
gptkb:BRCA1_mutations
BRCA2 mutations |
| gptkbp:is_monitored_by |
gptkb:MRI
ultrasound mammography |
| gptkbp:is_part_of |
patient support groups
breast cancer research cancer treatment guidelines cancer epidemiology breast cancer advocacy breast cancer awareness campaigns oncology studies breast cancer classification cancer survivorship studies |
| gptkbp:is_studied_in |
clinical trials
|
| gptkbp:occurs_in |
both men and women
|
| gptkbp:prevention |
healthy lifestyle
regular screenings |
| gptkbp:treatment |
gptkb:immunotherapy
gptkb:surgery chemotherapy targeted therapy hormonal therapy |
| gptkbp:bfsParent |
gptkb:Lynparza
|
| gptkbp:bfsLayer |
5
|